As of now, Germany reports a research & development by business enterprise, pharmaceutical industry in current ppp $ of 7,873.43 million, signifying an increase of 448.80 million (6.0%) from 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Germany
No matching regions
Similar regions to Germany
Business R&D pharmaceutical in current PPP $
More indicators for Germany
Government R&D in security as % of government support
4.2%
+0%
(2021)
Higher-education-finacing R&D financed by general university in local currency
53,957.00M
-1,258.00M
(2005)
R&D financed by rest of the world in local currency
78,509.07M
+600.72M
(2021)
Government R&D financed by rest of the world in local currency
10,120.47M
+1,554.23M
(2021)
Business R&D financed by rest of the world in local currency
59,822.55M
-513.58M
(2021)
Non-profit R&D growth rate
7.81%
+9.62%
(2022)
Germany Business R&D pharmaceutical in current PPP $ between 1991 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 7,873.43M | +448.80M |
| 2020 | 7,424.64M | -146.16M |
| 2019 | 7,570.79M | +464.37M |
| 2018 | 7,106.42M | +888.63M |
| 2017 | 6,217.79M | +214.79M |
| 2016 | 6,002.99M | +918.96M |
| 2015 | 5,084.04M | -162.95M |
| 2014 | 5,246.99M | -12.41M |
| 2013 | 5,259.40M | +61.53M |
| 2012 | 5,197.87M | +38.12M |
| 2011 | 5,159.75M | +518.80M |
| 2010 | 4,640.95M | -162.22M |
| 2009 | 4,803.17M | +641.43M |
| 2008 | 4,161.75M | +205.65M |
| 2007 | 3,956.10M | -357.15M |
| 2006 | 4,313.25M | +421.83M |
| 2005 | 3,891.42M | +283.14M |
| 2004 | 3,608.28M | +179.90M |
| 2003 | 3,428.38M | +693.00M |
| 2002 | 2,735.38M | +281.72M |
| 2001 | 2,453.66M | +76.97M |
| 2000 | 2,376.69M | +185.89M |
| 1999 | 2,190.80M | +188.13M |
| 1998 | 2,002.67M | +51.68M |
| 1997 | 1,950.99M | +387.10M |
| 1996 | 1,563.89M | +294.01M |
| 1995 | 1,269.88M | -74.56M |
| 1994 | 1,344.44M | -124.72M |
| 1993 | 1,469.15M | -76.05M |
| 1992 | 1,545.20M | -43.00M |
| 1991 | 1,588.20M |